OPTI — Optimi Health Income Statement
0.000.00%
- CA$17.88m
- CA$20.59m
- CA$0.39m
Annual income statement for Optimi Health, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.081 | 0.181 | 0.39 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.054 | 0.032 | 0.151 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.167 | 6.06 | 7.5 | 5.5 | 6.43 |
Operating Profit | -0.167 | -6.06 | -7.42 | -5.32 | -6.04 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.169 | -6.02 | -7.35 | -5.19 | -6.04 |
Net Income After Taxes | -0.169 | -6.02 | -7.35 | -5.19 | -6.04 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.169 | -6.02 | -7.35 | -5.19 | -6.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.169 | -6.02 | -7.35 | -5.19 | -6.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.004 | -0.116 | -0.094 | -0.061 | -0.069 |
Dividends per Share |